Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (32)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Linperlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Linperlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Milademetan	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Milademetan Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Navtemadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Onatasertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Onatasertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Patidegib	Hedgehog Pathway Inhibitor	Solid Tumour / Hematologic (AML)
Molecule Patidegib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Pictilisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Pictilisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Pilaralisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Pilaralisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Ridaforolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Ridaforolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sapanisertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Sapanisertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Serabelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Serabelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Siremadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Siremadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Sirolimus (Oncology Use)	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Sirolimus (Oncology Use) Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor

Linperlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Milademetan Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Onatasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Patidegib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Pictilisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Pilaralisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Ridaforolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Sapanisertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Serabelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Siremadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Sirolimus (Oncology Use) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor

‹ 1 2 3 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (32)

Linperlisib

Milademetan

Navtemadlin

Onatasertib

Patidegib

Pictilisib

Pilaralisib

Ridaforolimus

Sapanisertib

Serabelisib

Siremadlin

Sirolimus (Oncology Use)

Linperlisib

Milademetan

Navtemadlin

Onatasertib

Patidegib

Pictilisib

Pilaralisib

Ridaforolimus

Sapanisertib

Serabelisib

Siremadlin

Sirolimus (Oncology Use)